Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
76.79
-0.08 (-0.10%)
At close: Aug 12, 2026, 4:00 PM EDT
76.78
-0.01 (-0.01%)
After-hours: Aug 12, 2026, 4:47 PM EDT
Forte Biosciences Employees
Forte Biosciences had 22 employees as of March 31, 2026. The number of employees increased by 3 or 15.79% since the number was last reported on December 31, 2025.
Employees
22
Change
3
Growth
15.79%
Revenue / Employee
n/a
Profits / Employee
-$3,447,955
Market Cap
1.88B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 22 | 3 | 15.79% |
| Dec 31, 2025 | 19 | 5 | 35.71% |
| Dec 31, 2024 | 14 | 5 | 55.56% |
| Dec 31, 2023 | 9 | 3 | 50.00% |
| Dec 31, 2022 | 6 | 1 | 20.00% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Fortrea Holdings | 14,000 |
| Sarepta Therapeutics | 835 |
| Recursion Pharmaceuticals | 600 |
| Immunocore Holdings | 524 |
| Lakefront Biotherapeutics NV | 452 |
| Syndax Pharmaceuticals | 298 |
| Kardigan | 241 |
| Zenas BioPharma | 167 |
FBRX News
- 14 days ago - Halper Sadeh LLC is Investigating Whether FBRX and SAFT are Obtaining Fair Deals for their Shareholders - GlobeNewsWire
- 15 days ago - Forte Biosciences downgraded to Equal Weight from Overweight at Barclays - TheFly
- 16 days ago - After Forte acquisition, H.C. Wainwright says First Tracks could be target - TheFly
- 16 days ago - Forte Biosciences downgraded to Hold from Buy at Brookline - TheFly
- 16 days ago - Forte Biosciences downgraded to In Line from Outperform at Evercore ISI - TheFly
- 16 days ago - Forte Biosciences downgraded to Hold from Buy at TD Cowen - TheFly
- 16 days ago - M&A News: Forte Biosciences Shares Leap 40% After Argenx Seals $2.2B Immunology Deal - TipRanks
- 16 days ago - Argenx to acquire Forte Biosciences for $77 per share in cash - TheFly